Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Wakutani

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of Human Genetics|February 21, 2007
Molecular and clinical analyses of Japanese patients with carbamoylphosphate synthetase 1 (CPS1) deficiencyKeiji Kurokawa, Tohru Yorifuji, Masahiko Kawai, et al.
Molecular Cell|March 25, 2014
Largen: a molecular regulator of mammalian cell size controlKazuo Yamamoto, Valentina Gandin, Masato Sasaki, et al.
Journal of Alzheimer'S Disease : JAD|September 3, 2019
Clinical Benefits of Antioxidative Supplement Twendee X for Mild Cognitive Impairment: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Prospective Interventional StudyKoh Tadokoro, Ryuta Morihara, Yasuyuki Ohta, et al.
Journal of Alzheimer'S Disease : JAD|November 28, 2019
A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome TechnologyKoji Abe, Jingwei Shang, Xiaowen Shi, et al.
Geriatrics & Gerontology International|December 30, 2015
Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's diseaseKatsutoshi Furukawa, Naoki Tomita, Daisuke Uematsu, et al.
Neuron|November 4, 2015
ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule FunctionTetsuro Murakami, Seema Qamar, Julie Qiaojin Lin, et al.
Nature Genetics|January 16, 2007
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer diseaseEkaterina Rogaeva, Yan Meng, Joseph H Lee, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Human Genetics|February 21, 2007
Molecular and clinical analyses of Japanese patients with carbamoylphosphate synthetase 1 (CPS1) deficiencyKeiji Kurokawa, Tohru Yorifuji, Masahiko Kawai, et al.
Molecular Cell|March 25, 2014
Largen: a molecular regulator of mammalian cell size controlKazuo Yamamoto, Valentina Gandin, Masato Sasaki, et al.
Journal of Alzheimer'S Disease : JAD|September 3, 2019
Clinical Benefits of Antioxidative Supplement Twendee X for Mild Cognitive Impairment: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Prospective Interventional StudyKoh Tadokoro, Ryuta Morihara, Yasuyuki Ohta, et al.
Journal of Alzheimer'S Disease : JAD|November 28, 2019
A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome TechnologyKoji Abe, Jingwei Shang, Xiaowen Shi, et al.
Geriatrics & Gerontology International|December 30, 2015
Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's diseaseKatsutoshi Furukawa, Naoki Tomita, Daisuke Uematsu, et al.
Neuron|November 4, 2015
ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule FunctionTetsuro Murakami, Seema Qamar, Julie Qiaojin Lin, et al.
Nature Genetics|January 16, 2007
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer diseaseEkaterina Rogaeva, Yan Meng, Joseph H Lee, et al.
Pageof 4